Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.14365/5535
Title: | Pneumothorax as a Poor Prognostic Indicator in COVID-19 in Turkey: A Propensity Score Matching Analysis | Authors: | Özgel, M. Gülçek, I. Aǧar, M. Ulutaş, H. |
Keywords: | COVID-19; pneumothorax; prognostic factors; survival Adult; Aged; Comorbidity; COVID-19; Female; Humans; Male; Middle Aged; Pneumothorax; Prevalence; Prognosis; Propensity Score; Respiration, Artificial; Retrospective Studies; Risk Factors; SARS-CoV-2; Turkey; adult; aged; artificial ventilation; comorbidity; complication; coronavirus disease 2019; epidemiology; female; human; male; middle aged; mortality; pneumothorax; prevalence; prognosis; propensity score; retrospective study; risk factor; Severe acute respiratory syndrome coronavirus 2; turkey (bird) |
Publisher: | Wolters Kluwer Medknow Publications | Abstract: | Background: Spontaneous pneumothorax in COVID-19 occurs infrequently but in up to 15% of patients dependent on mechanical ventilation (MV). Pneumothorax-related deaths account for 1% of all COVID-19-related deaths. Aim: To determine factors associated with pneumothorax in COVID-19 patients and the effect of pneumothorax on early survival. Methods: This was a retrospective study of 4799 COVID-19-positive hospitalized patients. The groups were homogenized using propensity score matching (PSM) in two groups comprising 67 COVID-19 patients each. The prevalence of pneumothorax was determined. Multiple logistic regression was used to determine factors associated with pneumothorax. P value < 0.05 was taken as significant. Results: The prevalence of pneumothorax in COVID-19 patients was 1.6%. Lung disease, comorbidities, and oxygen support, which were significantly different between the two groups before PSM, were homogenized after PSM. In a univariate analysis, symptom duration (P 0.001), neutrophilia (P 0.001), lymphopenia (P 0.001), neutrophil-lymphocyte ratio (P = 0.003), ferritin levels (P = 0.012), D-dimer levels (P = 0.011), MV support (P 0.001), antibiotherapy (P 0.001), length of hospital stay (P = 0.009), and death (P = 0.002) differed significantly between the groups. Pneumothorax had a significant negative effect on survival (32.8% vs. 59.7%, P = 0.01). In a multivariate regression model, factors associated with pneumothorax were duration of symptoms (Adjusted Odds ratio (AOR) 1.68; 95% Confidence Interval (CI): 1.26-2.25; P = 0.001), mechanical ventilation (AOR 23.92; 95% CI: 4.12-138.72; P = <0.001), dual antibiotics (AOR 8.28; 95% CI: 1.56-43.86; P = 0.013), neutrophilia (AOR: 1.08; 95% CI: 1.02-1.14; P = 0.011), and lymphopenia (AOR: 0.92; 95% CI: 0.86-0.90; P = 0.022). Conclusion: The presence of pneumothorax was associated with poor survival in COVID-19 patients. Patients with a prolonged time from symptom onset to treatment and those dependent on mechanical ventilation in intensive care were in the high risk group for the development of pneumothorax. Copyright © 2024 Nigerian Journal of Clinical Practice. | URI: | https://doi.org/10.4103/njcp.njcp_785_23 https://hdl.handle.net/20.500.14365/5535 |
ISSN: | 1119-3077 |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection |
Show full item record
CORE Recommender
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.